RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept
  • Home
  • Impact
  • Publications
  • Comparison of Cholinesterase Inhibitor Utilization Patterns and Associated Health Care Costs in Alzheimer’s Disease

Comparison of Cholinesterase Inhibitor Utilization Patterns and Associated Health Care Costs in Alzheimer’s Disease

Mark, T., Mucha, L., Want, S. S., Cuffel, B., McRae, T., & Del Valle, M. (2008). Comparison of Cholinesterase Inhibitor Utilization Patterns and Associated Health Care Costs in Alzheimer’s Disease. Journal of Managed Care Pharmacy, 22(1), 451-461. [PMID: 18597574]. https://doi.org/10.18553/jmcp.2008.14.5.451

Abstract

Abstract

Sustained treatment with a cholinesterase inhibitor (ChEI) is used in the management of the symptoms of Alzheimer's disease (AD). However, the characteristic declines in learning and memory seen in AD may erode the patient's ability to adhere to medication regimens with or without caregiver support.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Meet the Experts

View All Experts
Tami Mark

Tami Mark

Recent Publications

Article

The evolution of minimally invasive tissue sampling in postmortem examination
Article

Accountability for SRHR in the context of the COVID-19 pandemic
Article

Validation of simple dichotomous self-report on prenatal alcohol and other drug use in women attending midwife obstetric units in the Cape Metropole, South Africa
Article

Progress in the solvent depolymerization of lignin